most popular glp 1 drugs What to Make of the GLP-1 Coverage and Cost Landscape Prescription Drug Spending Surges in

Obesity has further been associated with higher disease activity and reduced time to flare

Experts explain why hunger, food noise and other health changes return after stopping weight loss drugs and how to hold onto your progress.

Underwriters are treating your clients' dramatic weight loss as a red flag, not a health victory

This brief discusses the current landscape of Medicaid GLP-1 coverage and examines recent trends in Medicaid prescriptions and gross spending on GLP-1s.

Aims/hypothesis Regulators worldwide are reviewing safety data on glucagon-like peptide-1 receptor agonists (GLP-1RA), following reports by the Icelandic Medicines Agency in July 2023 of suicidal ideation and self-injury (SIS) in individuals taking liraglutide and semaglutide

WEEKS 35 EXPECTATIONS: As gut health and microbiome continue to improve, many users begin to notice more consistent digestive comfort and appetite awareness within 35 weeks of regular use